Active · per the CBE, 15 November 2026

JANS KINESITHERAPIE

BE0744521421

Rechtspersoon Private limited company 1 establishment

JANS KINESITHERAPIE is a physiotherapy practice in Alken. Private Limited, started on 27 February 2020, 1 establishment.

Hemelsveldstraat 96, 3570 Alken

Behind the company: Geoffrey Jans.

Active for

6 year, 8 months

Financials

Financial year 2025

JANS KINESITHERAPIE from Alken, company number BE0744521421, closed financial year 2025 with a result of € 8,213 after tax. For that financial year JANS KINESITHERAPIE recorded a gross margin of € 64,661 and equity of € 34,397. Compared with financial year 2024, the result moved from € 5,232 to € 8,213. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 16, 2026.

What it is worth Healthy

€ 34,397

▼ 47% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 8,213

▲ 57% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 67,095

▲ 53% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 38,486 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost estimate

€ 8,991

▲ 15% vs 2024

No payroll staff. An amount this small is usually a social contribution or pension premium for the director, booked under staff costs.

Vehicles and equipment

€ 5,809

▼ 37% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 8 years to go

€ 50,116

▼ 19% vs 2024

€ 6,114 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 23,471

▲ 13% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 3,367

▼ 1% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year
2022202320242025Change 2024 → 2025
Gross margin € 63,297 € 52,565 € 62,355 € 64,661 ▲ 4%
Profit after taxes € 17,519 € 1,646 € 5,232 € 8,213 ▲ 57%
Equity € 57,792 € 59,438 € 64,670 € 34,397 ▼ 47%
Total debts € 181,755 € 151,949 € 125,255 € 154,520 ▲ 23%
Cash € 50,469 € 41,935 € 43,816 € 67,095 ▲ 53%
Land & buildings € 125,279 € 103,275 € 92,605 € 78,093 ▼ 16%
Retained profit € 47,792 € 49,438 € 54,670 € 24,397 ▼ 55%
Dividend € 0 € 0 € 0 € 38,486
Bank debt € 83,714 € 72,515 € 62,157 € 50,116 ▼ 19%
Balance sheet total € 239,547 € 211,387 € 189,925 € 188,917 ▼ 1%

By gross margin, JANS KINESITHERAPIE ranks 5th of 9 companies with main activity “Activiteiten op het gebied van kinesitherapie” in Alken that publish figures (fiscal year 2025).

Key figures of JANS KINESITHERAPIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to JANS KINESITHERAPIE?

What happened at JANS KINESITHERAPIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 8,213 (▲ 57% vs 2024). Source: NBB ↗
  • Incorporation, published in the Gazette. Source: Staatsblad ↗
  • New establishment in Alken. KBO

In short

From € 17,519 profit in 2022 to € 8,213 profit in 2025.

Paid € 21,329 in corporate taxes since 2022.

Best year ever: 2022, with € 17,519 profit.

Paid out € 38,486 in dividends to the owners in total.

Management

Geoffrey Jans
JANS KINESITHERAPIE

Behind JANS KINESITHERAPIE is Geoffrey Jans.

Directors

According to the 2025 annual accounts

Geoffrey Jans

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Hemelsveldstraat 96

3570 Alken

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Alken

Same main activity (Activiteiten op het gebied van kinesitherapie), 11 active companies in Alken, largest first.

SJMB

€ 263,330 gross margin · 2025

PODOLOGIE PIETER VANSPAUWEN

€ 177,102 gross margin · 2025

KINERVUS

€ 132,836 gross margin · 2025

DE KOUTER M.S.

€ 83,529 gross margin · 2025

KINESITHERAPIE SMEETS

€ 43,889 gross margin · 2025

MEYSKENS MATTHIAS KINESITHERAPIE

€ 42,686 gross margin · 2025

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

Source: Deed ↗
  • Geoffrey JANS(oprichter) 100%

Details

Company number
0744.521.421
VAT number
BE 0744.521.421
Registered office
Hemelsveldstraat 96, 3570 Alken
Names & denominations
JANS KINESITHERAPIE
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
27 February 2020
Peppol
Active · Active since 5 Jun 2025
Activities · NACE

Activiteiten op het gebied van kinesitherapie

Ambulante revalidatieactiviteiten

Activiteiten van medisch specialisten

Overige vormen van onderwijs

Frequently asked questions

What does JANS KINESITHERAPIE do?
JANS KINESITHERAPIE is a physiotherapy practice in Alken. Private Limited, started on 27 February 2020, 1 establishment.
What is the address of JANS KINESITHERAPIE?
The registered office of JANS KINESITHERAPIE is located at Hemelsveldstraat 96, 3570 Alken.
Is JANS KINESITHERAPIE still active?
Yes. According to the CBE (15 November 2026) JANS KINESITHERAPIE is active, legal situation “Normale toestand”, started on 27 February 2020.
Is JANS KINESITHERAPIE registered on Peppol?
Yes, JANS KINESITHERAPIE is registered on the Peppol network with ID 0208:0744521421.
What is the enterprise number of JANS KINESITHERAPIE?
The enterprise number of JANS KINESITHERAPIE is BE0744521421.
When was JANS KINESITHERAPIE founded?
JANS KINESITHERAPIE was founded on 27 February 2020.